Merck
Search Within
Tipo de documento

552-94-3

Filtros aplicados
Palabra clave:'552-94-3'
Mostrando 1-23 of 23 resultados para "552-94-3" en el plazo de Documentación técnica
Data Sheet - F9925
Wallach, D., Nature, 388: 123 (1997). 21. Tschopp, J., et al., Curr. Opin. Immunol., 10: 22. 552-558 (1998). Notice We provide information and advice to our customers on application technologies
Product Information Sheet - CG5
1. The Merck Index, 13th ed., Entry# 2237. 2. Morgans, F.J., et al., Endocrinology, 94(6), 1601- 1606 (1974). 3. Hogan, B., et al., Manipulating the Mouse Embryo, A Laboratory Manual, 2nd ed.
Product Information Sheet - C1063
1. The Merck Index, 13th ed., Entry# 2237. 2. Morgans, F.J. et al., Endocrinology, 94(6), 1601- 1606 (1974). 3. Hogan, B. et al., Manipulating the Mouse Embryo, A Laboratory Manual, 2nd ed., Cold
Product Information Sheet - CG10
1. The Merck Index, 13th ed., Entry# 2237. 2. Morgans, F.J., et al., Endocrinology, 94(6), 1601- 1606 (1974). 3. Hogan, B., et al., Manipulating the Mouse Embryo, A Laboratory Manual, 2nd ed.
Data Sheet - C7706
ratio (F/P) of the product: 3.0 to 9.0 Spectral Characteristics of Cy3:15 Absorbance Max = 552 nm Emission Max = 570 nm Precautions and Disclaimer Due to the sodium azide content
XP725 Antibody Number-Lot Number 071M4826
500 521 522 523 524 545 546 547 548 569 570 571 572 6.6 501 502 503 504 525 526 527 528 549 550 551 552 573 574 575 576 7.1 577 578 579 580 601 602 603 604 625 626 627
S(–)-Blebbistatin: Selective inhibitor ofnon-muscle myosin II
Ogletree, M.L., et al., J. Pharmacol. Exp. Ther., 264, 570-578 (1993). 94. Armstrong, R.A., et al., Br. J. Pharmacol., 110, 548-552 (1993). 95. Wilson, T.W., Quest, D.W., Cardiovasc. Drug Rev., 18, 222-
Anti-NeuN, clone A60 - Data Sheet
Rubio, FJ, et al., Gene Therapy (1999) 6:1851-1866. 13) Gould, E., et al., Science (1999) 286:548-552. 14) Nichols, M., et al., Science (1999) 286:1558-1561. 15) Justicia, C. et al., Glia (2000) 30
Gelling Agents
differentiation of plant protoplasts immobilized in Ca-alginate beads. J. Plant Physiol. 132, 552-556 (1988) 3. Larkin, P.J., et al., Nurse culture of low numbers of Medicago and Nicotiana protoplasts using
Antibiotics and Antimycotics
differentiation of plant protoplasts immobilized in Ca-alginate beads. J. Plant Physiol. 132, 552-556 (1988) 3. Larkin, P.J., et al., Nurse culture of low numbers of Medicago and Nicotiana protoplasts using
Product Information Sheet - CKH200A
et al., Proc. Natl. Acad. Sci. USA, 72, 3666 (1975). 2. Beutler, B., et al., Nature, 316, 552 (1985). 3. Williams, T.W. and Granger, G.A., Nature, 219, 1076 (1968). 4. Ruddle, N.H. and Waksman
Product Information Sheet - CAT100
al., FEBS Lett., 442, 65-69 (1999). 7. Hampton, M.B., and Orrenius, S., FEBS Lett., 414, 552-556 (1997). 8. Kowaltowski, A.J. et al., FEBS Lett., 473, 177-182 (2000). 9. Tome, M.E. et al
TRAPeze® Kit RT Telomerase Detection Kit
utilizing energy transfer primers: comparison with gel- and ELISA-based detection. Biotechniques 26 (3):552-558. 20 Disclaimers SYBR® is a registered trademark of Molecular Probes.
hHCN1-HEK293 Recombinant Cell Line
bgh) polyadenylation signal is patented under U.S. Patent No. 5,122,458, European Patent No. 0 173 552, and Japanese Patent No. 6-83669. Use of the bgh polyadenylation signal found in screening systems
Impurities & Related Compounds: Reference Materials
145202-66-0 147098-20-2 94749-08-3 552-94-3 171599-83-0 53179-09-2 654671-77-9 9005-38-3 6018-19-5 497-19-8 15708-41-5 151-21-3 4070-80-8 15091-98-2 8025-81-8
XP725 Antibody List Lot 089K4791
Anti Cy3+Cy5 C0992 NA NA M 517 Nitrotyrosin N0409 NA NA P n/d n/d n/d 528 Anti Cy3+Cy5 C0992 NA NA M 552 Anti Cy3+Cy5 C0992 NA NA M 565 Phosphoserine P5747 NA NA M 566 Phosphothreonine P6623 NA NA M 567
XP725 Antibody List Lot 129K4831
Anti Cy3+Cy5 C0992 NA NA M 517 Nitrotyrosin N0409 NA NA P n/d n/d n/d 528 Anti Cy3+Cy5 C0992 NA NA M 552 Anti Cy3+Cy5 C0992 NA NA M 565 Phosphoserine P5747 NA NA M 566 Phosphothreonine P6623 NA NA M 567
XP725 Antibody List Lot 129K4830
Anti Cy3+Cy5 C0992 NA NA M 517 Nitrotyrosin N0409 NA NA P n/d n/d n/d 528 Anti Cy3+Cy5 C0992 NA NA M 552 Anti Cy3+Cy5 C0992 NA NA M 565 Phosphoserine P5747 NA NA M 566 Phosphothreonine P6623 NA NA M 567
Halal Certificate
ETHER, 99%, FG W366706 A85210 HC-23SIK425 551. DISODIUM SUCCINATE 98% W327700 B73688 HC-23SI3Y60 552. DL-ALANINE 99%, FCC, FG W381810 A30662 HC-23SIEO56 553. DL-Menthol W266507 C29015 HC-23SIOJ95
Halal Certificate
ETHER, 99%, FG W366706 A85210 HC-22SIU346 551. DISODIUM SUCCINATE 98% W327700 B73688 HC-22SICY81 552. DL-ALANINE 99%, FCC, FG W381810 A30662 HC-22SI4O77 553. DL-Menthol W266507 C29015 HC-22SIXV17
List of Antibodies
P5367&Brand=SIGMA� 588 Protein Kinase ζ P0713 P n/d y y 628 Rad17 R8029 P y n/d n/d 552 Anti Cy3+Cy5 C0992 M NA NA NA 553 γ Parvin P5746 M y n/d n/d 554
XP725 Antibody List
Apoptosis Response-4) P5367 5074, 64513, 114774 Pawr,PAWR NP_002574.2,NP_277020.1,NP_473397.1 P y y y 552 Anti Cy3+Cy5 553 γ Parvin P5746 64098 PARVG NP_071424.1 M y n/d n/d 554 Parkin P6248 5071, 50873, 56816
XP725 Antibody List 013M4793
Apoptosis Response-4) P5367 5074, 64513, 114774 Pawr,PAWR NP_002574.2,NP_277020.1,NP_473397.1 P y y y 552 Anti Cy3+Cy5 C0992 553 γ Parvin P5746 64098 PARVG NP_071424.1 M y n/d n/d 554 Parkin P6248 5071, 50873